
Leading pharmaceutical company Sun Pharma recently is launching Merck Sharpe Dohme (MSD) and Ridgeback’s COVID-19 antiviral drug molnupiravir, whileDrReddys also covers a large spectrum of COVID-19 products from prevention to treatment.
Jan 1, 2022 | tribuneindia.comIn September 2020, Sun Pharma announced the launch of ILUMYA® (tildrakizumab) for the treatment of plaque psoriasis, in Japan.
Jan 1, 2022 | wfmz.comLast week, Sun Pharmaceutical Industries said its unit has completed the $99.3 million acquisition of Alchemee from Galderma.
Jan 1, 2022 | moneycontrol.comSun Pharma Settles U.S. Antitrust Litigation For $485 Million Sun Pharmaceutical Industries Ltd. has agreed to pay $485 million (about Rs 3,700 crore) to settle an antitrust litigation for allegedly delaying generic versions of three drugs in the U.S.Sun Pharma and its U.S.-based subsidiary, Ranbaxy Inc., have signed a binding agreement with two plaintiff groups to settle claims regarding the antitrust litigation, the company said in an exchange filing.
Jan 1, 2022 | bloombergquint.comIndian drug major Sun Pharmaceutical Industries has entered into an exclusive patent licensing agreement with Danish CNS specialist Lundbeck to market and distribute its own version of vortioxetine in India.
Jan 1, 2022 | thepharmaletter.comIn 2016, Sun Pharma has introduced Bromsite, its first branded ophthalmic drug, in the U.S.
Jan 1, 2021 | medgadget.comThe Sun Pharm brand launched a campaign called #NekiEbadat that inspires people to take a step forward and help others in need which is a core principle of Islam.
Jan 1, 2022 | indiantelevision.comIn February 2021, Sun Pharmaceutical Industries on announced its plans to introduce a complete range of anti-epilepsy drug Brivaracetam in the India at an affordable price.
Jan 1, 2022 | digitaljournal.com"With disciplined cost reductions and the extension of the agreement with Sun Pharma, we believe that that Cipher now has a stable runway for growth.
Jan 1, 2022 | stockhouse.comAhmedabad: Sun Pharmaceutical Industries Ltd on Wednesday announced its wholly-owned subsidiary is soon to launch an oral lipid lowering drug, Bempedoic Acid, in India for reducing low-density lipoprotein (LDL) cholesterol.
Jan 1, 2022 | indiatimes.comSun Pharma has recently launched Ilumya and Cequa in Canada.
Jan 1, 2022 | business-standard.comAurobindo Pharmaceutical and Sun Pharma have been forced to recall their injectable treatment for vitamin B12 deficiency- Cyanocobalamin and dry eye drug Cequa, respectively, for the same reason.
Jan 1, 2022 | lifescivoice.comSun Pharma had then launched WINLEVI in the US market in November 2021.
Jan 1, 2022 | indiatimes.comSun Pharma launched Winlevi in the U.S. market in November 2021.
Jan 1, 2022 | drugstorenews.comLikewise, Ferring Pharmaceuticals added Ganirelix Acetate Injection to its product line in January 2019, acquiring the U.S. commercialization rights from Sun Pharmaceutical Industries Ltd.
Jan 1, 2021 | pharmiweb.comSun Pharma today announced that its chairman and member of the board, Israel Makov, will retire from the company upon the completion of his current term at Sun Pharma’s Annual General Meeting on Aug. 29, after having led the organization for 10 years.
Jan 1, 2022 | drugstorenews.comDebbie Ricciardelli was named manager fleet services at Sun Pharmaceuticals.
Jan 1, 2022 | globalfleetmanagement.comSun Pharma sued Hetero Healthcare for using the generic drug Letroz, which is used as a second-line treatment for advanced breast cancer, without permission.
Sep 6, 2022 | pharmastate.academyPharma major Sun Pharmaceutical, on Wednesday, said that it has acquired Pharmalucence Inc, a US based injectable company for an undisclosed sum.
Jan 31, 2017 | pharmatips.inDiana Harbort, CEO of Cassiopea SpA, commented: “QFR Solutions is very pleased to partner with Sun Pharma.
Jul 25, 2021 | qfrsolutions.comIn October 2021, Sun Pharma launched PrILUMYA (tildrakizumab injection) for people with moderate-to-severe plaque psoriasis in the Canada region.
Nov 21, 2022 | asdreports.comRs 10 crore on Sun Pharma for expanding its drug manufacturing facility in Maduranthagam allegedly without required environmental clearance from the concerned authority.
Dec 6, 2022 | pharmastate.academyAs a part of the assessment conducted by Great Place To Work® India, Sun Pharma was recognised among India’s Best Workplaces™ in Pharmaceuticals, Healthcare and Biotech 2022.
Dec 22, 2022 | indiaeducationdiary.in